View of THE INFLUENCE OF CURRENT RATIO, TOTAL ASSET TURNOVER, AND R&D INTENSITY ON RETURN ON COMPANY ASSET IN THE PHARMACY SECTOR LISTED ON IDX FOR THE 2018-2023 PERIOD

Return to Article Details THE INFLUENCE OF CURRENT RATIO, TOTAL ASSET TURNOVER, AND R&D INTENSITY ON RETURN ON COMPANY ASSET IN THE PHARMACY SECTOR LISTED ON IDX FOR THE 2018-2023 PERIOD Download Download PDF